Launch of Tripo P1.0 signals the arrival of AI 3D 2.0 — where speed, quality, and production usability finally converge SAN FRANCISCO, March 9, 2026 /PRNewswire/ -- Tripo AI today announced plans to ...
* Says diffusion plans to initiate this clinical trial by end of 2017 * Diffusion Pharmaceuticals- interacting with FDA regarding design, execution of planned phase 3 study, with initiation planned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results